Page last updated: 2024-09-03

sr 48692 and Central Nervous System Diseases

sr 48692 has been researched along with Central Nervous System Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ardecky, RJ; Bai, Y; Barak, LS; Caron, MG; Chung, TDY; Falter, B; Hedrick, MP; Hershberger, P; Jackson, MR; Maloney, P; Peddibhotla, S; Pinkerton, AB; Slosky, LM; Smith, LH; Yamamoto, F	1

Other Studies

1 other study(ies) available for sr 48692 and Central Nervous System Diseases

Article	Year
Discovery of β-Arrestin Biased, Orally Bioavailable, and CNS Penetrant Neurotensin Receptor 1 (NTR1) Allosteric Modulators. Journal of medicinal chemistry, 2019, 09-12, Volume: 62, Issue:17 Topics: Administration, Oral; Allosteric Regulation; Animals; beta-Arrestins; Biological Availability; Central Nervous System Diseases; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Drug Discovery; Female; Locomotion; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Structure; Quinazolines; Rats; Receptors, Neurotensin; Structure-Activity Relationship	2019

Article

Year

Discovery of β-Arrestin Biased, Orally Bioavailable, and CNS Penetrant Neurotensin Receptor 1 (NTR1) Allosteric Modulators.

Journal of medicinal chemistry, 2019, 09-12, Volume: 62, Issue:17

Topics: Administration, Oral; Allosteric Regulation; Animals; beta-Arrestins; Biological Availability; Central Nervous System Diseases; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Drug Discovery; Female; Locomotion; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Structure; Quinazolines; Rats; Receptors, Neurotensin; Structure-Activity Relationship

2019